Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Eitner

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Therapeutic targets for prevention and regression of progressive fibrosing renal diseasesFrank Eitner, Jürgen Floege
Seminars in Nephrology|January 29, 2008
Immune modulating therapy for IgA nephropathy: rationale and evidenceJürgen Floege, Frank Eitner
Current Opinion in Nephrology and Hypertension|April 17, 2003
Novel insights into renal fibrosisFrank Eitner, Jürgen Floege
Kidney International|August 16, 2012
In search of a better understanding of IgA nephropathy-associated hematuriaFrank Eitner, Jürgen Floege
Nature Reviews. Nephrology|October 27, 2009
Glomerular disease: sugars and immune complex formation in IgA nephropathyJonathan Barratt, Frank Eitner
Journal of the American Society of Nephrology : JASN|September 10, 2011
Current therapy for IgA nephropathyJürgen Floege, Frank Eitner
Current Opinion in Nephrology and Hypertension|June 18, 2015
Nonsteroidal antagonists of the mineralocorticoid receptorPeter Kolkhof, Christina Nowack, Frank Eitner
Pediatric Nephrology (Berlin, Germany)|May 21, 2011
The PDGF family in renal fibrosisTammo Ostendorf, Frank Eitner, Jürgen Floege
Journal of the American Society of Nephrology : JASN|December 14, 2007
A new look at platelet-derived growth factor in renal diseaseJürgen Floege, Frank Eitner, Charles E Alpers
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 13, 2016
Con: STOP immunosuppression in IgA nephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Current Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Therapeutic targets for prevention and regression of progressive fibrosing renal diseasesFrank Eitner, Jürgen Floege
Seminars in Nephrology|January 29, 2008
Immune modulating therapy for IgA nephropathy: rationale and evidenceJürgen Floege, Frank Eitner
Current Opinion in Nephrology and Hypertension|April 17, 2003
Novel insights into renal fibrosisFrank Eitner, Jürgen Floege
Kidney International|August 16, 2012
In search of a better understanding of IgA nephropathy-associated hematuriaFrank Eitner, Jürgen Floege
Nature Reviews. Nephrology|October 27, 2009
Glomerular disease: sugars and immune complex formation in IgA nephropathyJonathan Barratt, Frank Eitner
Journal of the American Society of Nephrology : JASN|September 10, 2011
Current therapy for IgA nephropathyJürgen Floege, Frank Eitner
Current Opinion in Nephrology and Hypertension|June 18, 2015
Nonsteroidal antagonists of the mineralocorticoid receptorPeter Kolkhof, Christina Nowack, Frank Eitner
Pediatric Nephrology (Berlin, Germany)|May 21, 2011
The PDGF family in renal fibrosisTammo Ostendorf, Frank Eitner, Jürgen Floege
Journal of the American Society of Nephrology : JASN|December 14, 2007
A new look at platelet-derived growth factor in renal diseaseJürgen Floege, Frank Eitner, Charles E Alpers
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 13, 2016
Con: STOP immunosuppression in IgA nephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
Pageof 9